These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23430276)

  • 1. The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.
    Hindle JV
    J Neural Transm (Vienna); 2013 Apr; 120(4):649-53. PubMed ID: 23430276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric aspects of Parkinson's disease--an update.
    Schrag A
    J Neurol; 2004 Jul; 251(7):795-804. PubMed ID: 15258780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 9. Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
    Espay AJ; Guskey MT; Norton JC; Coate B; Vizcarra JA; Ballard C; Factor SA; Friedman JH; Lang AE; Larsen NJ; Andersson C; Fredericks D; Weintraub D
    Mov Disord; 2018 Nov; 33(11):1769-1776. PubMed ID: 30387904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine as a treatment for psychosis in Parkinson's disease: a review.
    Musser WS; Akil M
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):1-9. PubMed ID: 8845691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
    Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA
    CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for depression and psychosis in Parkinson's disease.
    Poewe W; Seppi K
    J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson disease psychosis: Update.
    Friedman JH
    Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.